Nanostructured Lipid Carriers: A Review

A. Sharma, Ashish Baldi
{"title":"Nanostructured Lipid Carriers: A Review","authors":"A. Sharma, Ashish Baldi","doi":"10.4172/2329-6631.1000191","DOIUrl":null,"url":null,"abstract":"Lipid-containing drug delivery systems like NLC are well-established methods for preparing pharmaceuticals for all major kind of drug delivery systems of nanoscience. Lipid formulations require a variety of product-related requirements and problems associated with NLC, which is discussed thoroughly in this chapter. There are multiple DDS currently available which leads to enhance the solubility of the drugs in different medium as well as also increase the bioavailability of the drugs in different conditions and environments. NLC’s are a novel type of DDS which are stable in different environment and which have capabilities to form concentrated dispersions. In this chapter, we discussed different process variables, steps involved in the manufacturing of NLC and responses with their outcome. NLC’s can increase the drug distribution to the target organ, change the pharmacokinetic characteristics of drug carriers to enhance the therapeutic effect, and reduce adverse side effects.","PeriodicalId":15589,"journal":{"name":"Journal of Developing Drugs","volume":"102 1","pages":"0-0"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"18","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Developing Drugs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2329-6631.1000191","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 18

Abstract

Lipid-containing drug delivery systems like NLC are well-established methods for preparing pharmaceuticals for all major kind of drug delivery systems of nanoscience. Lipid formulations require a variety of product-related requirements and problems associated with NLC, which is discussed thoroughly in this chapter. There are multiple DDS currently available which leads to enhance the solubility of the drugs in different medium as well as also increase the bioavailability of the drugs in different conditions and environments. NLC’s are a novel type of DDS which are stable in different environment and which have capabilities to form concentrated dispersions. In this chapter, we discussed different process variables, steps involved in the manufacturing of NLC and responses with their outcome. NLC’s can increase the drug distribution to the target organ, change the pharmacokinetic characteristics of drug carriers to enhance the therapeutic effect, and reduce adverse side effects.
纳米结构脂质载体研究进展
像NLC这样的含脂药物传递系统是制备药物的成熟方法,适用于所有主要的纳米科学药物传递系统。脂质配方需要与NLC相关的各种产品相关要求和问题,本章将对此进行深入讨论。目前已有多种DDS,可提高药物在不同介质中的溶解度,提高药物在不同条件和环境下的生物利用度。nlc是一种新型的DDS,在不同的环境中具有稳定性和形成集中分散的能力。在本章中,我们讨论了不同的过程变量,在NLC制造过程中所涉及的步骤以及它们的结果的响应。nlc可以增加药物向靶器官的分布,改变药物载体的药代动力学特性,提高治疗效果,减少不良副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信